APA (7th ed.) Citation

Sivignon, M., Monnier, R., Tehard, B., & Roze, S. Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Sivignon, Marine, Rémi Monnier, Bertrand Tehard, and Stéphane Roze. Cost-effectiveness of Alectinib Compared to Crizotinib for the Treatment of First-line ALK+ Advanced Non-small-cell Lung Cancer in France. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Sivignon, Marine, et al. Cost-effectiveness of Alectinib Compared to Crizotinib for the Treatment of First-line ALK+ Advanced Non-small-cell Lung Cancer in France. Public Library of Science (PLoS).